SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Learn how Cytopeutics partnered with Syngene to conduct safety and tumorigenicity studies for its hMSC product in appropriate animal models as per regulatory guidelines.
Learn how Syngene is achieving three to four-fold higher titers of mAbs using its Intensified Fed-Batch process
Read our blogs for industry insights and best practices…
Visit Syngene virtually via our 360 degree lab tours…
View our webinars on cutting edge science topics and insights…
Read our latest PoVs and White papers….
© 2023. Syngene International Limited
